Loading
A phase 3 trial of durvalumab, carboplatin, pemetrexed, paclitaxel / nab-paclitaxel and other drugs in lung cancer, run by Maximilian Diehn, now recruiting.
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC is a phase 3, interventional study registered as NCT04585490 by Maximilian Diehn, with a registry enrolment figure of 48 participants, started 2021-08-25 and due to reach its primary completion in 2026-08. Interventions recorded: Durvalumab; Carboplatin; Pemetrexed; Paclitaxel; Cisplatin; AVENIO ctDNA Surveillance Kit; Tremelimumab. Conditions listed: Non Small Cell Lung Cancer; NSCLC, Stage III; Nsclc. Primary outcome: Change in ctDNA Level Following Chemotherapy. Lung eligibility wording from the registry: "Histologically- or cytologically-documented NSCLC presenting with locally-advanced, unresectable stage III disease (Version 8 of AJCC Staging Manual) or NSCLC with locoregional recurrence after previous definitive treatment". Sites: United States. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Durvalumab, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Durvalumab, Lung cancer trials open today (registry snapshot), AstraZeneca, Platinum agents and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Durvalumab, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Pemetrexed, Durvalumab, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents and the tag lung-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/